Nanoparticle Delivery of Cannabinoid Receptor Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering cannabinoid receptor binding agents are limited in their ability to effectively target and treat skin conditions and other dermatological issues, as they often struggle with penetration through the skin's barrier and sustained release profiles.
Innovation Solution
The development of compositions and methods for topical delivery of cannabinoid receptor binding agents using nanoparticles and polymeric vehicles, which facilitate transdermal and mucosal delivery, allowing for targeted binding to specific receptors and sustained release, enhancing therapeutic efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional delivery methods are used for cannabinoid receptor binding agents, then the administration process is simple, but the penetration through skin barrier is insufficient and therapeutic efficacy is limited
Solution Approach 1:
The patent introduces nanoparticles as intermediary carriers to facilitate the delivery of cannabinoid receptor binding agents through the skin barrier. These nanoparticles act as mediators that enable deeper penetration and sustained release of the therapeutic agents, resolving the contradiction between simple administration and effective delivery.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the delivery system by using nanoparticles with specific size ranges (1-1000 nm) and controlled release characteristics. This parameter optimization enables enhanced skin penetration while maintaining sustained therapeutic action, addressing the efficacy-complexity trade-off.
2Length of moving object
If topical delivery systems are used, then local administration is achieved, but penetration depth into the skin is insufficient
Solution Approach 1:
The patent optimizes the particle size parameter of the delivery system to 1-1000 nm range, which enables deeper penetration into skin layers while maintaining effective concentrations of the therapeutic agent. This parameter control allows sufficient penetration depth without requiring excessive amounts of the active substance.
3Duration of action of moving object
If sustained release profiles are implemented, then therapeutic action is extended, but the delivery system complexity increases
Solution Approach 1:
The patent employs nanoparticles as intermediary carriers that inherently provide sustained release capabilities through their controlled release mechanisms. This intermediary approach extends therapeutic action duration without requiring complex external release control systems, as the nanoparticle structure itself facilitates gradual agent release.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables deeper penetration of cannabinoid receptor binding agents into the skin, improving treatment outcomes for conditions like psoriasis, wound healing, and skin cancers by ensuring effective receptor binding and sustained therapeutic action.
Implementation Method 1
topical delivery of cannabinoid receptor binding agents, and in particular embodiments, cannabinoid receptor binding agents attached to a nanoparticle
Data Source
AI summary
A composition comprising a cannabinoid receptor binding agent attached to a particle for the treatment of skin conditions. The particle may be a nanoparticle, such as nanocrystalline cellulose. The particle may further be modified with functional moieties. Drug delivery properties may be modified by coating the particles or using vesicles to deliver the cannabinoid receptor binding agent and particle. A substrate may be used to deliver the composition to the skin.